Severe disseminated constrictive polyserositis in a patient with rheumatoid arthritis


Cite item

Full Text

Abstract

Constrictive polyserositis (pleuritis, pericarditis) is a syndrome within the underlying disease (tuberculosis, periodic disease, rheumatoid arthritis, systemic lupus erythematosus, asbestos, silicosis, uremia, some genetic diseases), a complication due to chest surgery or radiation or drug therapy, is occasionally idiopathic (fibrosing mediastinitis). There are frequently great difficulties in making its nosological diagnosis.
The paper describes a patient in whom the onset of disease was exudative pleurisy with the signs of constriction, arthralgias; pleural punctures provided serous exudates with 80% lymphocytes. A year later there was ascitis and shin and foot edemas, which concurrent with hepatomegaly and cholestasis was regarded as cryptogenic liver cirrhosis. The signs of constrictive pericarditis were further revealed. The disease was complicated by the development of pulmonary artery thromboembolism (PATE) (which required the use of warfarin) and hemorrhagic vasculitis. Therapy with metipred in combination with isoniazid yielded a slight effect. The diagnoses of tuberculosis, liver cirrhosis, and autoimmune hepatitis, systemic vasculitis were consecutively rejected; the diagnosis of rheumatoid polyarthritis with systemic manifestations was made, by taking into account persistent arthalgias with the minimum signs of arthritis, noticeably increased C-reactive protein, rheumatoid factor, and cyclic citrullinated peptide antibodies (CCPA); plasmapheresis, therapy with metipred and methotrexate, and subtotal pericardectomy were performed.
Constrictive polyserositis concurrent with PATE, hemorrhagic vasculitis (probably, drug-induced one), and hepatic lesion has been first described in a CCPA-positive patient with rheumatoid arthritis in the presence of moderate true arthritis (during steroid therapy).

About the authors

O V Blagova

I. M. Sechenov Moscow Medical Academy

Email: blagova@mail.ru
Кафедра факультетской терапии № 1 лечебного факультетаканд. мед. наук, доц; ММА им. И. М. Сеченова; I. M. Sechenov Moscow Medical Academy

D A Tsaregorodtsev

I. M. Sechenov Moscow Medical Academy

Email: tsaregorodtsev@mail.ru
Кафедра факультетской терапии № 1 лечебного факультетаканд. мед. наук, доц; ММА им. И. М. Сеченова; I. M. Sechenov Moscow Medical Academy

A V Nedostup

I. M. Sechenov Moscow Medical Academy

Email: avnedostup@mail.ru
Кафедра факультетской терапии № 1 лечебного факультетад-р мед. наук, проф; ММА им. И. М. Сеченова; I. M. Sechenov Moscow Medical Academy

I V Mayevskaya

I. M. Sechenov Moscow Medical Academy

зав., кардиологическое отд-ние факультетской терапевтической клиники им. В. Н. Виноградова; ММА им. И. М. Сеченова; I. M. Sechenov Moscow Medical Academy

N V Petukhova

I. M. Sechenov Moscow Medical Academy

Email: petuhova_nv@mail.ru
зав., артрологическое отд-ние; ММА им. И. М. Сеченова; I. M. Sechenov Moscow Medical Academy

M P Troitskaya

I. M. Sechenov Moscow Medical Academy

Email: maria_nemo@mail.ru
Кафедра факультетской терапии № 1 лечебного факультетаклинический ординатор; ММА им. И. М. Сеченова; I. M. Sechenov Moscow Medical Academy

Ya R Shadania

I. M. Sechenov Moscow Medical Academy

Кафедра факультетской терапии № 1 лечебного факультетаклинический ординатор; ММА им. И. М. Сеченова; I. M. Sechenov Moscow Medical Academy

References

  1. Tamir R., Pick A. J., Theodor E. Constrictive pericarditis complicating dermatomyositis. Ann. Rheum. Dis. 1988; 47 (11): 961-963.
  2. Wolf R. E., King J. W., Brown T. A. Antimyosin antibodies and constrictive pericarditis in lupus erythematosus. J. Rheumatol. 1988; 15 (8): 1284-1287.
  3. Dyer N. H., Varley C. C. Letter: practolol-induced pleurisy and constrictive pericarditis. Br. Med. J. 1975; 2 (5968): 443.
  4. Verma U. N., Misra R., Radhakrisnan S. et al. A syndrome of fibrosing pleuritis, pericarditis, and synovitis with infantile contractures of fingers and toes in 2 sisters: "familial fibrosing serositis". J. Rheumatol. 1995; 22 (12): 2349-2355.
  5. Hayes J. P., Wiggins J., Ward K. et al. Familial cryptogenic fibrosing pleuritis with Fanconi's syndrome (renal tubular acidosis). A new syndrome. Chest 1995; 107 (2): 576-583.
  6. Buchanan D. R., Johnston I. D., Kerr I. H. et al. Cryptogenic bilateral fibrosing pleuritis. Br. J. Dis. Chest 1988; 82 (2): 186-193.
  7. Oliver R. M., Neville E. Progressive apical pleural fibrosis: a 'constrictive' ventilatory defect. Br. J. Dis. Chest 1988; 82 (4): 439-443.
  8. Ohnishi Y., Katada H., Kasuga H. et al. An operative case of chronic constrictive pericarditis with silicosis and lumbar caries. Kekkaku 1990; 65 (3): 237-242.
  9. Tada Y., Onoue H., Koarada S. et al. A case of idiopathic fibrosing mediastinitis presented with bilateral pleural effusion. Nihon Rinsho Meneki Gakkai Kaishi 2002; 25 (2): 177-180.
  10. Devaraj A., Griffin N., Nicholson A. G., Padley S. P. Computed tomography findings in fibrosing mediastinitis. Clin. Radiol. 2007; 62 (8): 781-786.
  11. Ahmad M., Weinstein A. J., Hughes J. A., Cosgrove D. E. Granulomatous mediastinitis due to Aspergillus flavus in a nonimmunosuppressed patient. Am. J. Med. 1981; 70 (4): 887-890.
  12. Rossi S. E., McAdams H. P., Rosado-de-Christenson M. L. et al. Fibrosing mediastinitis. Radiographics 2001; 21 (3): 737- 757.
  13. Thould A. K. Constrictive pericarditis in rheumatoid arthritis. Ann. Rheum. Dis. 1986; 45 (2): 89-94.
  14. Bologna C., Poirier J. L., Hérisson C., Simon L. Constrictive pericarditis in severe seronegative rheumatoid polyarthritis. Rev. Med. Interne 1992; 13 (1): 64-68.
  15. Hakala M., Pettersson T., Tarkka M. et al. Rheumatoid arthritis as a cause of cardiac compression. Favourable long-term outcome of pericardiectomy. Clin. Rheumatol. 1993; 12 (2): 199-203.
  16. Manji H., Raven P. Calcific constrictive pericarditis due to rheumatoid arthritis. Postgrad. Med. J. 1990; 66 (771): 57-58.
  17. Thadani U., Iveson J. M., Wright V. Cardiac tamponade, constrictive pericarditis and pericardial resection in rheumatoid arthritis. Medicine (Baltimore) 1975; 54 (3): 261-270.
  18. Séve P., Stankovic K., Broussolle C. Effectiveness of colchicines in a case of recurrent compressive rheumatoid pericarditis. Rheumatol. Int. 2005; 25 (7): 558-561.
  19. Anaya J. M., Diethelm L., Ortiz L. A. et al. Pulmonary involvement in rheumatoid arthritis. Semin. Arthr. Rheum. 1995; 24 (4): 242-254.
  20. Schwarz M. I., Zamora M. R., Hodges T. N. et al. Isolated pulmonary capillaraitis and diffuse alveolar hemorrhage in rheumatoid arthritis and mixed connective tissue disease. Chest 1998; 113 (6): 1609-1615.
  21. L'Huillier J. P., Desrues B., Chales G. et al. Idiopathic pulmonary hemosiderosis and rheumatoid arthritis. Apropos of a case. Rev. Pneumol. Clin 1988; 44 (3): 136-139.
  22. Unlüer E. E., Denizbasi A. A pulmonary embolism case presenting with upper abdominal and flank pain. Eur. J. Emerg. Med. 2003; 10 (2): 135-138.
  23. Hashimoto K., Nakanishi H., Yamasaki A. et al. Pulmonary findings without the influence of therapy in a patient with rheumatoid arthritis: an autopsy case. J. Med. Invest. 2007; 54 (3-4): 340-344.
  24. Linde B., Oelzner P., Katenkamp K. et al. Fulminate liver failure in a 39-year-old female patient with leukocytosis, unclear fever, and arthralgic pain. Med. Klin. 2007; 102 (10): 846- 851.
  25. Miyachi K., Takano S., Sekiyama N. et al. Two cases of rheumatoid arthritis presenting autoimmune hepatic diseases. Ryumachi 1994; 34 (3): 639-645.
  26. Nakano T., Ishibashi H., Matsui M. et al. A case of primary biliary cirrhosis with negative anti-mitochondrial antibody anteceded by rheumatoid arthritis. Fukuoka Igaku Zasshi 1992; 83 (3): 144-148.
  27. Ergun T., Inanc N., Tuney D. et al. Skin manifestations of rheumatoid arthritis: a study of 215 Turkish patients. Int. J. Dermatol. 2008; 47 (9): 894-902.
  28. Стерлинг Дж. Вест. Секреты ревматологии: Пер. с англ. под ред. В. Н. Хирманова. М.: Бином; СПб.: Невский диалект; 2001.
  29. Chan Y. C., Valenti D., Mansfield A. O., Stansby G. Warfarin induced skin necrosis. Br. J. Surg. 2000; 87 (3): 266-272.
  30. Kapoor K. G., Bekaii-Saab T. Warfain-induced allergic interstitial nephritis and leukocytoclastic vasculitis. Intern. Med. J. 2008; 38 (4): 281-283.
  31. Yaghoubian B., Ngo B., Mak M. et al. Warfarin-induced leukocytoclastic vasculitis. Cutis 2005; 75 (6): 329-338.
  32. Schellekens G. A., de Jong B. A., van den Hoogen F. H. et al. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J. Clin. Invest. 1998; 101 (1): 273-281.
  33. Shi J., Sun X., Zhan Y. et al. Prevalence and significance of antibodies to citrullinated human papilloma virus-47 E2345-362 in rheumatoid arthritis. J. Autoimmun. 2008; 31 (2): 131- 135.
  34. Schellekens G. A., Visser H., de Jong B. A. et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthr. and Rheum. 2000; 43 (1): 155-163.
  35. Беляева И. Б., Лапин С. В., Созина А. В. и др. Антитела к цитруллинсодержащим антигенам в диагностике и прогнозировании течения раннего ревматоидного артрита. Мед. иммунол. 2007; 9 (1): 77-84.
  36. Girelli F., Foschi F. G., Bedeschi E. et al. Is anti-cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis? Eur. Ann. Allergy Clin. Immunol. 2004; 36 (4): 127-130.
  37. Enriconi Dos Anjos L. M., Pereira I. A. et al. A comparative study of IgG second- and third-generation anti-cyclic citrullinated peptide (CCP) ELISAs and their combination with IgA third-generation CCP ELISA for the diagnosis of rheumatoid arthritis. Clin. Rheumatol. 2009; 28 (2): 153-158.
  38. Hayashi N., Nishimura K., Kumagai S. New biomarkers for rheumatoid arthritis. Rinsho Byori 2008; 56 (4): 297-308.
  39. Sghiri R., Bouajina E., Bargaoui D. Value of anti-mutated citrullinated vimentin antibodies in diagnosing rheumatoid arthritis. Rheumatol. Int. 2008; 29 (1): 59-62.
  40. Cho S. Y., Kang S. Y., Lee H. J., Lee W. I. A comparative evaluation of the diagnostic value of anti-cyclic citrullinated peptide and rheumatoid factor in rheumatoid arthritis. Korean J. Lab. Med. 2008; 28 (1): 39-45.
  41. Koca S. S., Akbulut H., Dag S. et al. Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis and Behcet's disease. Tohoku J. Exp. Med. 2007; 213 (4): 297-304.
  42. Riccio A., Postiglione L., La Dogana P. et al. Anti-cyclic citrullinated peptide antibodies in patients affected by HCV-related arthritis. J. Biol. Regul. Homeost. Agents 2008; 22 (1): 57-61.
  43. Bombardieri M., Alessandri C., Labbadia G. et al. Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement. Arthr. Res. Ther. 2004; 6 (2): R137-R141.
  44. Damiän-Abrego G. N., Cabiedes J., Cabral A. R. Anti-citrullinated peptide antibodies in lupus patients with or without deforming arthropathy. Lupus 2008; 17 (4): 300-304.
  45. Chan M. T., Owen P., Dunphy J. et al. Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC class II alleles in systemic lupus erythematosus. J. Rheumatol. 2008; 35 (1): 77-83.
  46. Candia L., Marquez J., Gonzalez C. et al. Low frequency of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis. J. Clin. Rheumatol. 2006; 12 (5): 226-229.
  47. Morita Y., Muro Y., Sugiura K., Tomita Y. Anti-cyclic citrullinated peptide antibody in systemic sclerosis. Clin. Exp. Rheumatol. 2008; 26 (4): 542-545.
  48. Koca S. S., Akbulut H., Dag S. et al. Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis and Behcet's disease. Tohoku J. Exp. Med. 2007; 213 (4): 297-304.
  49. Kakumanu P., Yamagata H., Sobel E. S. et al. Patients with pulmonary tuberculosis are frequently positive for anti-cyclic citrullinated peptide antibodies, but their sera also react with modified arginine-containing peptide. Arthr. and Rheum. 2008; 58 (6): 1576-1581.
  50. Nisihara R. M., Skare T. K., Silva M. B. et al. High positivity of anti-CCP antibodies in patients with Down syndrome. Clin. Rheumatol. 2007; 26 (12): 2031-2035.
  51. Lee D. M., Phillips R., Hagan E. M. et al. Quantifying anti-CCP titer: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis. Ann. Rheum. Dis. 2009; 68 (2): 201-208.
  52. Kroot E. J., de Jong B. A., van Leeuwen M. A. et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthr. and Rheum. 2000; 43 (8): 1831-1835.
  53. Kim S. K., Park S. H., Shin I. H., Choe J. Y. Anti-cyclic citrullinated peptide antibody, smoking, alcohol consumption, and disease duration as risk factors for extraarticular manifestations in Korean patients with rheumatoid arthritis. J. Rheumatol. 2008; 35 (6): 995-1001.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies